Itaconate suppresses neonatal intestinal inflammation via metabolic reprogramming of M1 macrophage
Authors:
Open Access
- 17 July 2025
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 15 (7) , e70419
Abstract
Background: Necrotizing enterocolitis (NEC) is a rapidly progressive and severe gastrointestinal disorder in neonates that is marked by an inflammatory cascade initiated by mechanisms that remain incompletely understood, resulting in intestinal necrosis and systemic infections. This study demonstrated that itaconate (ITA) exerts a protective effect in NEC by regulating macrophage reprogramming.Methods: Changes in ITA expression were investigated using immunofluorescence staining and liquid chromatography‐mass spectrometry, and their effect on immune cell differentiation was verified through single‐cell sequencing. In vivo experiments were performed using ACOD1−/‐ and ACOD1fl/flLysMcre NEC mouse models.Results: We detected changes in ITA expression in clinical NEC samples and confirmed the effect of these changes on immune cell differentiation. In vivo experiments confirmed the therapeutic role of ITA in regulating macrophage differentiation in NEC, and we further investigated the mechanism by which ITA regulates macrophage metabolic reprogramming. The depletion of ITA in NEC correlates with an increased frequency of pro‐inflammatory macrophage polarization, thereby exacerbating intestinal inflammatory injury. Importantly, our in vivo experiments revealed that treatment with 4‐octyl itaconate (4OI) significantly mitigated intestinal symptoms associated with NEC in murine models. Mechanistic investigations showed that 4OI effectively suppressed M1 macrophage polarization by rescuing mitochondrial function and upregulating oxidative phosphorylation in macrophages.Conclusions: Our results highlight ITA as a metabolic checkpoint of macrophage differentiation in NEC and suggest the therapeutic efficacy of 4OI in NEC.Key points: Itaconate alleviates NEC by reprogramming M1 macrophage metabolism ACOD1 deficiency exacerbates NEC severity 4OI maintains intestinal barrier integrity. 4OI rescues NEC by regulating macrophage mitochondrial activity.Keywords
This publication has 45 references indexed in Scilit:
- IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory PropertiesCell Metabolism, 2019
- Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Nature, 2018
- Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammationNature Medicine, 2018
- Necrotizing enterocolitis: new insights into pathogenesis and mechanismsNature Reviews Gastroenterology & Hepatology, 2016
- Immunometabolism governs dendritic cell and macrophage functionJournal of Experimental Medicine, 2015
- Abolition of mitochondrial substrate‐level phosphorylation by itaconic acid produced by LPS‐induced Irg1 expression in cells of murine macrophage lineageThe FASEB Journal, 2015
- Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid productionProceedings of the National Academy of Sciences, 2013
- Necrotizing EnterocolitisNew England Journal of Medicine, 2011
- Mitochondria and Reactive Oxygen SpeciesHypertension, 2009
- Neonatal Necrotizing EnterocolitisAnnals of Surgery, 1978